Pricing the EpiPen: Drug Prices, Corporate Governance, and the Financialization of Biomedicine — Danya Glabau

Why does Mylan’s EpiPen cost so much? Read my early-stage reflections on the matter over at Somatosphere in a recent blog post.

via Pricing the EpiPen: Drug Prices, Corporate Governance, and the Financialization of Biomedicine — Danya Glabau

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s